Timed killing kinetic studies of the interaction between ciprofloxacin and β-lactams against gram-negative bacilli

Diagnostic Microbiology and Infectious Disease

Volumn 26, Issue 1, 1996, Pages 29-33

  Pohlman, Janice K ^a,b   Knapp, Cynthia C ^a   Ludwig, Margaret D ^a   Washington, John A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Department of Infectious Diseases ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; PIPERACILLIN; TAZOBACTAM; TICARCILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENTEROBACTER CLOACAE; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZTREONAM; CEFTAZIDIME; CEPHALOSPORINS; CIPROFLOXACIN; CLAVULANIC ACID; CLAVULANIC ACIDS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ENTEROBACTER CLOACAE; ENZYME INHIBITORS; KINETICS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MONOBACTAMS; PENICILLANIC ACID; PENICILLINS; PIPERACILLIN; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; TICARCILLIN; TIME FACTORS;

EID: 0030249414     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(96)00174-5     Document Type: Article

References (11)

1. Bustamante CI, Wharton RC, Wade JC (1990) Activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 34: 1814-1815.
2. Cappelletty DM, Rybak MJ (1996) Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 40:677-683.
3. Chin NX, Jules K, Neu HC (1986) Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection. Eur J Clin Microbiol 5:23-28.
4. Davies GSR, Cohen J (1985) In-vitro study of the activity of ciprofloxacin alone and in combination against strains of Pseudomonas aeruginosa with multiple antibiotic resistance. J Antimicrob Chemother 16:713-717.
5. Eliopoulos GM, Moellering RC Jr (1991) Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 3rd edition, Ed, V. Lorian. Baltimore: Williams & Wilkins, pp. 432-492.
6. Forstall GJ, Knapp CC, Washington JA (1994) Bactericidal activities of DU-6859a and clinafloxacin (CI-960) against staphylococci. Antimicrob Agents Chemother 38:1868-1870.
7. Haller I (1986) Comprehensive evaluation of ciprofloxacin in combination with β-lactam antibiotics Enterobacteriaceae and Pseudomonas aeruginosa. Drug Res 36:226-229.
8. Hooper DC, Wolfson JS (1993) Mechanisms of quinolone action and bacterial killing. In Quinolone Antimicrobial Agents, 2nd edition, Eds, DC Hooper, JS Wolfson. Washington, DC: American Society for Microbiology, pp. 53-75.
9. Meyer RD, Liu S (1988) In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multi-drug-resistant Pseudomonas aeruginosa. Diagn Microbiol Infect Dis 11:151-157.
10. Moodie JA, Gerding DN, Peterson LR (1987) Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods. Am J Med 92(suppl 4A):44-54.
11. Yorassowsky E, Van der Linden MP, Crokaert F, Glupczynski Y (1988) Effect of antibiotic carry-over on bacterial counting by "spiral plating." J Antimicrob Chemother 21:138-140